Towa Pharmaceutical Co., Ltd. (TWAPF)
25.98
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
Towa Pharmaceutical Gross Profit Margin (Quarterly) : 36.56% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 36.56% |
| March 31, 2026 | 34.44% |
| December 31, 2025 | 37.93% |
| September 30, 2025 | 36.02% |
| June 30, 2025 | 36.34% |
| March 31, 2025 | 36.42% |
| December 31, 2024 | 36.73% |
| September 30, 2024 | 35.46% |
| June 30, 2024 | 37.31% |
| March 31, 2024 | 35.19% |
| December 31, 2023 | 36.38% |
| September 30, 2023 | 34.50% |
| June 30, 2023 | 36.68% |
| March 31, 2023 | 31.64% |
| December 31, 2022 | 35.82% |
| September 30, 2022 | 36.58% |
| June 30, 2022 | 36.34% |
| March 31, 2022 | 41.05% |
| December 31, 2021 | 42.41% |
| September 30, 2021 | 43.56% |
| June 30, 2021 | 42.51% |
| March 31, 2021 | 43.80% |
| December 31, 2020 | 41.27% |
| September 30, 2020 | 42.11% |
| June 30, 2020 | 40.53% |
| Date | Value |
|---|---|
| March 31, 2020 | 44.42% |
| December 31, 2019 | 44.65% |
| September 30, 2019 | 47.60% |
| June 30, 2019 | 46.85% |
| March 31, 2019 | 46.42% |
| December 31, 2018 | 47.88% |
| September 30, 2018 | 43.96% |
| June 30, 2018 | 45.50% |
| March 31, 2018 | 44.35% |
| December 31, 2017 | 46.37% |
| September 30, 2017 | 49.38% |
| June 30, 2017 | 44.26% |
| March 31, 2017 | 44.98% |
| December 31, 2016 | 46.60% |
| September 30, 2016 | 47.25% |
| June 30, 2016 | 44.97% |
| March 31, 2016 | 51.90% |
| December 31, 2015 | 50.31% |
| September 30, 2015 | 51.15% |
| June 30, 2015 | 50.54% |
| March 31, 2015 | 52.68% |
| December 31, 2014 | 55.59% |
| September 30, 2014 | 48.39% |
| June 30, 2014 | 49.60% |
| March 31, 2014 | 45.34% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 57.57% |
| Daiichi Sankyo Co., Ltd. | 78.37% |
| Eisai Co., Ltd. | 78.20% |
| Chugai Pharmaceutical Co., Ltd. | 69.49% |
| Santen Pharmaceutical Co., Ltd. | 54.66% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.73% |
| Return on Assets | 1.78% |
| Return on Invested Capital | 2.07% |
| Profit Margin (Quarterly) | 7.75% |
| Operating Margin (Quarterly) | 9.13% |
| Return on Net Operating Assets | 2.13% |